Anjan Aralihalli

Anjan Aralihalli is an accomplished professional in the life sciences sector with extensive experience in executive leadership, business development, and venture capital. As the founder of Raya Therapeutic, Inc., Anjan focuses on developing disease-modifying therapies for neurodegenerative diseases. Anjan serves as a venture partner at CTI Life Sciences Fund and is a board member of the Muscular Dystrophy Association, contributing to innovations in care for neuromuscular diseases. Anjan has held key positions at several organizations, including Chief Business Officer at GLyPharma Therapeutic and Vice President of Business Development at Intrexon Corporation. Anjan's educational background includes a Master of Science in Biotechnology from The Johns Hopkins University and an MBA in Finance from Queen's University.